A proteomic atlas of the neointima identifies novel druggable targets for preventive therapy
European Heart Journal

Abstract
In-stent restenosis is a complication after coronary stenting associated with morbidity and mortality. Here, we sought to investigate the molecular processes underlying neointima formation and to identify new treatment and prevention targets.
Neointima formation was induced by wire injury in mouse femoral arteries. High-accuracy proteomic measurement of single femoral arteries to a depth of about 5000 proteins revealed massive proteome remodelling, with more than half of all proteins exhibiting expression differences between injured and non-injured vessels. We observed major changes in the composition of the extracellular matrix and cell migration processes. Among the latter, we identified the classical transient receptor potential channel 6 (TRPC6) to drive neointima formation. While
Our study provides a proteomic atlas of the healthy and injured arterial wall that can be used to define novel factors for therapeutic targeting. We present TRPC6 as an actionable target to prevent neointima formation secondary to vascular injury and stent implantation.
Contributors

Michael Wierer
Author

Julia Werner
Author

Jana Wobst
Author

Ganildo Cepele
Author

Redouane Aherrahrou
Author

Jeanette Erdmann
Author

Martin Dichgans
Author

Veit Flockerzi
Author

Mete Civelek
Author

Alexander Dietrich
Author

Matthias Mann
Author

Heribert Schunkert
Author
You may be interested in






